TALWIN: PENTAZOCINE LACTATE INJECTION.
The PENTAZOCINE LACTATE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: BOTTLE, protective_storage_feature: SECURITY STORAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 10.000 MILLILITERS, controlled_substance_classification: SCHEDULE IV, active_medicament_medicinal_strength: 30.000 MILLIGRAMS PENTAZOCINE PER MILLILITER. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-180-6030, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| protective_storage_feature | SECURITY STORAGE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 10.000 MILLILITERS |
| controlled_substance_classification | SCHEDULE IV |
| active_medicament_medicinal_strength | 30.000 MILLIGRAMS PENTAZOCINE PER MILLILITER |
| part_name_assigned_by_controlling_agency | PENTAZOCINE LACTATE INJECTION USP 30MG/ML 10ML VIAL |
| NSN | 6505-00-180-6030 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PENTAZOCINE AND NALOXONE HYROCHLORIDE TABLETS USP 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS NALOXONE HYDROCHLORIDE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS PENTAZOCINE HYDROCHLORIDE ACTIVE INGREDIENT |